Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 1998

View Archived Issues

IL-4(38-37)-PE38KDEL treatment results in complete regression of human glioblastoma tumors

Company Profile: Prolifix

PSA is a useful indicator of prostate cancer in finasteride-treated patients

Roche: half-year 1998 highlights

EntreMed signs CRADA with NCI to advance Endostatin protein studies

FDA clears new product for facilitating GTR procedures

NCI to sponsor pivotal phase III trials of AEterna's Neovastat

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Pacific Pharmaceuticals initiates NCI-sponsored trial at Duke University Medical Center

Phase IIb trial results confirm efficacy and safety of INKP-100 for colonoscopy

Ixion's method of producing islet cells to be covered by U.S. patent

Anergen in-licenses MHC II-peptide complex with potential applications in MS

Novel antiinflammatory azulenes disclosed by Kotobuki

Japan Energy presents new HIV protease inhibitors

Meiji Seika's new macrolides active against Gram-positive microorganisms

Pfizer identifies glycogen phosphorylase inhibitor as potent antidiabetic agent

Preparation and antibacterial activity of new cephems disclosed by Otsuka

Sankyo patents series with dual NK1/NK2-antagonist activity

International team reports discovery of novel immunostimulants

Orion receives EU approval to market Parkinson's disease treatment

Another treatment option added to the anti-HIV arsenal: efavirenz gets FDA approval

Bayer strengthens diagnostics division with acquisition of Chiron subsidiary

New cardioprotectant from RPR shows potential in treating acute myocardial infarction

Infasurf product launch delayed again

ACAT inhibitor synthesized at Slovakofarma and presented at EFMC symposium

Cognition enhancer on the clinical track at Dainippon

Shareholders approve acquisition; AVI BioPharma up and running

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...